Search
for
Sort by
Research 30 of 1000+
- Fructose-1,6-bisphosphate aldolase A levels decrease in hair keratinocytes during androgenetic alopecia
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- A comparative study of Aldactone® and Diane® in the treatment of hirsutism
- Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study
- Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?
- The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Kaempferol Rhamnosides from Geranium sibiricum as Aldose Reductase Inhibitors and Their Content by HPLC Analysis
- Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity
- Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications
- Mechanistic Underlying Anti-diabetic Potential of Eclipta alba Flavonoids against Aldose Reductase Inhibitory Action
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- A Novel Use of Spironolactone: Treatment of Hirsutism
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
- Management of Transgenderism
- Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia
- Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial1
- Endocrine intervention for transsexuals
- Management of acne
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- The effect of spironolactone on genital skin 5α-reductase activity
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Acne in the adult female patient: a practical approach
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Hormonal Treatment of Transgender Women with Oral Estradiol
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19